Passage Bio, Inc. (PASG) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -12.99M | -6.48M | -4.85M | -6.33M | -13.85M | -8.44M | -7.45M | -13.14M | -18.93M | -19.52M | -19.16M | -17.14M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 6.21% | 23.27% | 34.83% | 51.81% | 26.85% | 56.73% | 61.14% | 23.36% | 15.67% | 18.75% | 18.09% | 34.29% |
| Net Income | -7.56M | -12.98M | -7.75M | -9.38M | -15.4M | -12.72M | -19.34M | -15.99M | -16.71M | -16.76M | -27.11M | -23.86M |
| Depreciation & Amortization | 129K | 177K | 200K | 169K | 201K | 719K | 759K | 797K | 806K | 807K | 958K | 978K |
| Stock-Based Compensation | 0 | 609K | 0 | 923K | 858K | 1.25M | 1.4M | 1.58M | 1.59M | 1.57M | 2.82M | 3.74M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.66M | 11.28M | 0 |
| Other Non-Cash Items | -77K | -507K | 592K | 14K | 2.77M | -365K | 4.37M | 141K | -444K | 3.81M | -6.21M | -308K |
| Working Capital Changes | -5.48M | 6.22M | 2.1M | 1.95M | -2.27M | 2.68M | 5.36M | 339K | -4.17M | -4.29M | -906K | 2.3M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 197K | 161K | 66K | 937K | 716K | -747K | 868K | -1.07M | 389K | -1.47M | -634K | 357K |
| Cash from Investing | 20K | 0 | 0 | 585K | 39.63M | 13.68M | 14.97M | 1.05M | 25.25M | 7.6M | 22.45M | 13.97M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -14K | -20K | 0 | 0 | -13K | -4K | -103K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 20K | 0 | 0 | 585K | 585K | 0 | 0 | 0 | 0 | -7.61K | -22.45K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.61K | 22.45K | 0 |
| Cash from Financing | 0 | 9K | 0 | 14K | 0 | 47K | 0 | 85K | 8.74M | 46K | 0 | 89K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 9K | 0 | 14K | 0 | 47K | 0 | 50K | 8.74M | 46K | 0 | 89K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 14K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35K | 0 | 0 | 0 | 0 |
| Net Change in Cash | -12.97M | -6.47M | -4.85M | -5.73M | 25.78M | 5.28M | 7.52M | -12M | 15.06M | -11.87M | 3.29M | -3.08M |
| Free Cash Flow | -12.99M | -6.48M | -4.85M | -6.33M | -13.85M | -8.46M | -7.47M | -13.14M | -18.93M | -19.53M | -19.17M | -17.24M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 6.21% | 23.4% | 35.01% | 51.81% | 26.85% | 56.69% | 61.04% | 23.81% | 15.77% | 28.97% | 18.92% | 35.94% |
| FCF per Share | -4.05 | -2.04 | -1.53 | -2.00 | -4.46 | -2.73 | -2.42 | -4.26 | -6.72 | -7.11 | -7.00 | -6.31 |
| FCF Conversion (FCF/Net Income) | 1.72x | 0.50x | 0.63x | 0.67x | 0.90x | 0.66x | 0.39x | 0.82x | 1.13x | 1.16x | 0.71x | 0.72x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |